AAGH PDUFA date: FDA decision expected April 30, 2027

The FDA is expected to decide on this application from America Great Health by the PDUFA target action date of April 30, 2027. NDA filing. Extracted from: Kowa Pharmaceuticals America Announces FDA Acceptance of New Drug Application for K-911, an Investigational IOP-Lowering Eye Drop for Patients with Open-Angle Glaucoma or Ocular Hypertension

A PDUFA date is the FDA's target deadline to complete its review of a drug application — approval, a complete response letter (CRL), or an extension are all possible. What is a PDUFA date? This page is research information, not financial advice.